(-)-Scopolamine hydrobromide - Moligand™, ≥98% , Antagonist of M 1 receptor;Antagonist of M 2 receptor;Antagonist of M 3 receptor;Antagonist of M 4 receptor;Antagonist of M 5 receptor, CAS No.114-49-8, Antagonist of M 1 receptor;Antagonist of M 2 receptor;Antagonist of M 3 receptor;Antagonist of M 4 receptor;Antagonist of M 5 receptor

CAS: 114-49-8 Cat. No.: S302239 Molecular Weight: 384.26 EC Number: 204-050-6 PubChem CID: 6603108

GRADE & PURITY Moligand™, ≥98%

Synonyms

(-)-Hyoscine hydrobromide | CAS-114-49-8 | HY-N0296A | HYOSCINE HYDROBROMIDE [WHO-DD] | NSC8847 | R3K67DRL3J | WTGQALLALWYDJH-WYHSTMEOSA-N | (?,S)-?-(Hydroxymethyl)benzeneacetic acid (1?,2?,4?,5?,7?)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Overview

Scopolamine hydrobromide is a high affinity (nM) muscarinic antagonist. 5-HT3 receptor-responses are reversibly inhibited by Scopolamine with an IC50 of 2.09 μM.

Specifications

Synonyms

(-)-Hyoscine hydrobromide | CAS-114-49-8 | HY-N0296A | HYOSCINE HYDROBROMIDE [WHO-DD] | NSC8847 | R3K67DRL3J | WTGQALLALWYDJH-WYHSTMEOSA-N | (?, S)-?-(Hydroxymethyl)benzeneacetic acid (1?, 2?, 4?, 5?, 7?)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02, 4]non-7-yl ester

Specifications & Purity

Moligand™, ≥98%

Biochemical and Physiological Mechanisms

Competitive, non-selective muscarinic antagonist. Standard tool for measurement of cognitive impairment in vivo .

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

This product requires cold chain shipping. Ground and other economy services are not available.

Grade

Moligand™

Action Type

ANTAGONIST

Mechanism of action

Antagonist of M 1 receptor;Antagonist of M 2 receptor;Antagonist of M 3 receptor;Antagonist of M 4 receptor;Antagonist of M 5 receptor

Note

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Purity

≥98%

Names and Identifiers

• Pubchem Sid: 508811734
• Canonical Smiles: CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br
• IUPAC Name: [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;hydrobromide
• InChIKey: WTGQALLALWYDJH-WYHSTMEOSA-N
• INCHI: 1S/C17H21NO4.BrH/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10;/h2-6,11-16,19H,7-9H2,1H3;1H/t11?,12-,13-,14+,15-,16+;/m1./s1
• Isomeric SMILES: CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4.Br
• PubChem CID: 6603108
• Molecular Weight: 384.26

Taxonomic Classification

Taxonomy Tree

• Kingdom Organic compounds
  • Superclass Organic acids and derivatives
    • Class Hydroxy acids and derivatives
      • Subclass Beta hydroxy acids and derivatives

• Kingdom: Organic compounds
• Superclass: Organic acids and derivatives
• Class: Hydroxy acids and derivatives
• Subclass: Beta hydroxy acids and derivatives
• Intermediate Tree Nodes: Not available
• Direct Parent: Beta hydroxy acids and derivatives
• Alternative Parents: Piperidines N-alkylpyrrolidines Morpholines Benzene and substituted derivatives Trialkylamines Amino acids and derivatives Carboxylic acid esters Oxacyclic compounds Azacyclic compounds Monocarboxylic acids and derivatives Epoxides Dialkyl ethers Hydrobromides Carbonyl compounds Hydrocarbon derivatives Organic oxides Primary alcohols
• Molecular Framework: Aromatic heteropolycyclic compounds
• Substituents: Beta-hydroxy acid - Monocyclic benzene moiety - Morpholine - Oxazinane - Piperidine - N-alkylpyrrolidine - Benzenoid - Pyrrolidine - Amino acid or derivatives - Carboxylic acid ester - Tertiary amine - Tertiary aliphatic amine - Azacycle - Organoheterocyclic compound - Oxacycle - Carboxylic acid derivative - Dialkyl ether - Oxirane - Ether - Monocarboxylic acid or derivatives - Primary alcohol - Organic oxide - Organonitrogen compound - Organooxygen compound - Amine - Hydrocarbon derivative - Carbonyl group - Organic oxygen compound - Organic nitrogen compound - Alcohol - Hydrobromide - Aromatic heteropolycyclic compound
• Description: This compound belongs to the class of organic compounds known as beta hydroxy acids and derivatives. These are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom.
• External Descriptors: Not available

Data sources

1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.

DOI: 10.1186/s13321-016-0174-y

Associated Targets(Human)

CHRM5 Tclin Muscarinic acetylcholine receptor M5 (0 Activities)

Discover Target: CHRM5

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 (1 Activities)

Discover Target: CHRM3

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CHRM4 Tclin Muscarinic acetylcholine receptor M4 (1 Activities)

Discover Target: CHRM4

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CHRM2 Tclin Muscarinic acetylcholine receptor M2 (1 Activities)

Discover Target: CHRM2

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 (1 Activities)

Discover Target: CHRM1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Mechanisms of Action

Chemical and Physical Properties

• Solubility: Soluble in water (77 mg/mL), DMSO (77 mg/mL), Insoluble in ethanol.
• Sensitivity: Moisture sensitive
• Melt Point(°C): 195-199 °C (dry matter)(lit.)
• Molecular Weight: 384.300 g/mol
• Hydrogen Bond Donor Count: 2
• Hydrogen Bond Acceptor Count: 5
• Rotatable Bond Count: 5
• Exact Mass: 383.073 Da
• Monoisotopic Mass: 383.073 Da
• Topological Polar Surface Area: 62.300 Ų
• Heavy Atom Count: 23
• Formal Charge: 0
• Complexity: 418.000
• Isotope Atom Count: 0
• Defined Atom Stereocenter Count: 5
• Undefined Atom Stereocenter Count: 0
• Defined Bond Stereocenter Count: 0
• Undefined Bond Stereocenter Count: 0
• The total count of all stereochemical bonds: 0
• Covalently-Bonded Unit Count: 2

XLogP3

References

1. Guoxing Wang, Jiyu Du, Jie Ma, Peipei Liu, Siqi Xing, Jucheng Xia, Shuanghong Dong, Zeng Li.  (2023)  Discovery of Novel Tryptanthrin Derivatives with Benzenesulfonamide Substituents as Multi-Target-Directed Ligands for the Treatment of Alzheimer’s Disease.  Pharmaceuticals,  16  (10): (1468).  [PMID:37895939] [10.3390/ph16101468]

2. Xi Zhu, Yangjing Lv, Miaoliang Fan, Jianan Guo, Yujia Zhang, Bianbian Gao, Changjun Zhang, Yuanyuan Xie.  (2023)  Exploration of the novel phthalimide-hydroxypyridinone derivatives as multifunctional drug candidates against Alzheimer’s disease.  BIOORGANIC CHEMISTRY,      [PMID:37690318] [10.1016/j.bioorg.2023.106817]

3. Changjun Zhang, Yujia Zhang, Yangjing Lv, Jianan Guo, Bianbian Gao, Yi Lu, Anjie Zang, Xi Zhu, Tao Zhou, Yuanyuan Xie.  (2023)  Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer’s disease.  JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY,      [PMID:36519319] [10.1080/14756366.2022.2134358]

4. Chuansheng Yao, Xiaoying Jiang, Rui Zhao, Zhichao Zhong, Jiamin Ge, Junlong Zhu, Xiang-Yang Ye, Yuanyuan Xie, Zhen Liu, Tian Xie, Renren Bai.  (2022)  HDAC1/MAO-B dual inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid/o-aminobenzamide hybrids.  BIOORGANIC CHEMISTRY,      [PMID:35305483] [10.1016/j.bioorg.2022.105724]

5. Min Wang, Longji Fang, Tongtong Liu, Xuejie Chen, Yan Zheng, Yilong Zhang, Shiming Chen, Zeng Li.  (2021)  Discovery of 7-O-1, 2, 3-triazole hesperetin derivatives as multi-target-directed ligands against Alzheimer's disease.  CHEMICO-BIOLOGICAL INTERACTIONS,      [PMID:33905740] [10.1016/j.cbi.2021.109489]

6. Yilei Song, Xiangyu Wang, Xingrong Wang, Jianze Wang, Qiulian Hao, Jifu Hao, Xueqin Hou.  (2021)  Osthole-Loaded Nanoemulsion Enhances Brain Target in the Treatment of Alzheimer’s Disease via Intranasal Administration.  Oxidative Medicine and Cellular Longevity,      [PMID:33564364] [10.1155/2021/8844455]

7. Huimin Wu, Longfei Lin, Xueying Du, Lingling Zhang, Xingbin Yin, Xiaoxv Dong, Xiaofeng Hao, Like Xie, Changhai Qu, Jian Ni.  (2020)  Study on the potential effective ingredients of Xiaosheng prescription for dry eye disease.  BIOMEDICINE & PHARMACOTHERAPY,      [PMID:32428832] [10.1016/j.biopha.2020.110051]

8. Xiaomeng Xu, Rong Liang, Dongmei Li, Chengyao Jiang, Songyi Lin.  (2020)  Evaluation of sea cucumber peptides-assisted memory activity and acetylation modification in hippocampus of test mice based on scopolamine-induced experimental animal model of memory disorder.  Journal of Functional Foods,      [PMID:] [10.1016/j.jff.2020.103909]

9. Huihong Zeng, Huan Li, Mengzhen Yue, Ying Fan, Jiaoqi Cheng, Xincheng Wu, Rui Xu, Wuping Yang, Manjun Li, Jiahui Tang, Hongping Chen, Bohai Kuang, Guangqin Fan, Qingxian Zhu, Lijian Shao.  (2019)  Isoprenaline protects intestinal stem cells from chemotherapy-induced damage.  BRITISH JOURNAL OF PHARMACOLOGY,  177  (3): (687-700).  [PMID:31648381] [10.1111/bph.14883]

10. Yu-Min Xu, Xin-Chen Wang, Ting-Ting Xu, Hong-Ying Li, Shang-Yan Hei, Na-Chuan Luo, Hong Wang, Wei Zhao, Shu-Huan Fang, Yun-Bo Chen, Li Guan, Yong-Qi Fang, Shi-Jie Zhang, Qi Wang, Wei-Xiong Liang.  (2019)  Kai Xin San ameliorates scopolamine-induced cognitive dysfunction.  Neural Regeneration Research,      [PMID:30688265] [10.4103/1673-5374.249227]

11. Jing Zhang, Jun Wang, Gui-Sheng Zhou, Ya-Jie Tan, Hui-Juan Tao, Jia-Qian Chen, Zong-Jin Pu, Jia-Yan Ma, Wen She, An Kang, Yue Zhu, Pei Liu, Zhen-Hua Zhu, Xu-Qin Shi, Yu-Ping Tang, Jin-Ao Duan.  (2019)  Studies of the Anti-amnesic Effects and Mechanisms of Single and Combined Use of Donepezil and Ginkgo Ketoester Tablet on Scopolamine-Induced Memory Impairment in Mice.  Oxidative Medicine and Cellular Longevity,      [PMID:30911351] [10.1155/2019/8636835]

12. Sun Kaiyue, Bai Yuting, Zhao Rong, Guo Zijiao, Su Xiang, Li Peiqi, Yang Pengyu.  (2018)  Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress.  METABOLIC BRAIN DISEASE,  34  (1): (173-181).  [PMID:30406376] [10.1007/s11011-018-0335-y]

13. Yao Chen, Jie Zhu, Jun Mo, Hongyu Yang, Xueyang Jiang, Hongzhi Lin, Kai Gu, Yuqiong Pei, Liang Wu, Renxiang Tan, Jing Hou, Jingyi Chen, Yang Lv, Yaoyao Bian, Haopeng Sun.  (2018)  Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease.  JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY,      [PMID:29278947] [10.1080/14756366.2017.1412314]

14. Liang Meng, Pinjia Meng, Bugang Tang, Qingqing Zhang, Yanji Wang.  (2013)  Molecularly imprinted photonic hydrogels for fast screening of atropine in biological samples with high sensitivity.  FORENSIC SCIENCE INTERNATIONAL,      [PMID:23890610] [10.1016/j.forsciint.2013.04.008]

15. Yao Chen, Jianfei Sun, Lei Fang, Mei Liu, Sixun Peng, Hong Liao, Jochen Lehmann, Yihua Zhang.  (2012)  Tacrine–Ferulic Acid–Nitric Oxide (NO) Donor Trihybrids as Potent, Multifunctional Acetyl- and Butyrylcholinesterase Inhibitors.  JOURNAL OF MEDICINAL CHEMISTRY,      [PMID:22512543] [10.1021/jm300106z]

16. Hong Yao, Giuseppe Uras, Pengfei Zhang, Shengtao Xu, Ying Yin, Jie Liu, Shuai Qin, Xinuo Li, Stephanie Allen, Renren Bai, Qi Gong, Haiyan Zhang, Zheying Zhu, Jinyi Xu.  (2021)  Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease.  JOURNAL OF MEDICINAL CHEMISTRY,      [PMID:34024109] [10.1021/acs.jmedchem.1c00160]

17. Li Ming-Jie, Xu Jing-Yi, Zhang Hua-Yue, Guo Min, Lan Meng-Ning, Kong Jie, Liu Shi-Wei, Zheng Hua-Jun.  (2024)  A medicine and food homology formula prevents cognitive deficits by inhibiting neuroinflammation and oxidative stress via activating AEA–Trpv1–Nrf2 pathway.  INFLAMMOPHARMACOLOGY,      [PMID:39305407] [10.1007/s10787-024-01570-4]

18. Yuanfang Sun, Qi Xia, Lijing Du, Yu Gan, Xiaopeng Ren, Gang Liu, Yongkuan Wang, Shikai Yan, Shasha Li, Xiuyun Zhang, Xue Xiao, Huizi Jin.  (2024)  Neuroprotective effects of Anshen Bunao Syrup on cognitive dysfunction in Alzheimer's disease rat models.  BIOMEDICINE & PHARMACOTHERAPY,      [PMID:38810401] [10.1016/j.biopha.2024.116754]

19. Juan Wang, Jialuo Zhang, Shujing Liu, Jing Tang, Jiajun Liu, Ying Huang, Huazhang Zeng, Hu Yang, Boxuan Li.  (2025)  Cationic liposome-mediated scavenging of cell-free DNA: An innovative and alternative therapeutic approach for efficient treatment of dry eye disease.  CHEMICAL ENGINEERING JOURNAL,      [PMID:] [10.1016/j.cej.2025.167638]

20. Ming Shao, Yu Chai, Yutong Jiang, Xinyi Wu, Wenjie Xie, Jiayi Lu, Xuehui Fu, Yao He, Xiaofeng Zhang, Han Zhang, Zhuang Liu.  (2025)  Eye-Drop Nano-Formulation of Catalase Self-Assembled with Thiolated Chitosan for Effective Treatment of Dry Eye Disease.  ADVANCED MATERIALS,  37  (19): (2415353).  [PMID:40123221] [10.1002/adma.202415353]

21. Boda Li, Junpeng Liu, Di Zhang, Yiran Chu, Zeying Chen, Jiaruei Tsao, Taige Chen, Jiaxuan Jiang, Kai Hu.  (2025)  Evodiamine Promotes Autophagy and Alleviates Oxidative Stress in Dry Eye Disease Through the p53/mTOR Pathway.  INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE,  66  (3): (44-44).  [PMID:40111353] [10.1167/iovs.66.3.44]

22. Sun Yuanfang, Shao Mingguo, Du Lijing, Gan Yu, Guan Yongxia, Cheng Guoliang, Li Shasha, Jin Huizi, Li Bing, Zhang Guimin, Yan Shikai, Xiao Xue.  (2025)  Exploring neuroprotective effects of Chuanzhitongluo capsule on an alzheimer’s disease rat model.  METABOLIC BRAIN DISEASE,  41  (1): (5).  [PMID:41417293] [10.1007/s11011-025-01772-x]

23. Zeying Chen, Yun Tang, Jiaxuan Jiang, Di Zhang, Yiran Chu, Boda Li, Qi Zhang, Huayong Zhang, Kai Hu.  (2025)  Inhibition of Histone Methyltransferase G9a Activates Autophagy and Provides Protection in Dry Eye Disease.  INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE,  66  (14): (52-52).  [PMID:41263610] [10.1167/iovs.66.14.52]